JINCHANG, China, Jan. 28, 2026 /PRNewswire/ — On January 15, Li Ping, an enterprise person in charge, praised sincerely after finishing business at the power supply window of Jinchang Government Service Center: “With Party members’ assistance and ‘joint service’ windows, handling electricity procedures has become much easier.” State Grid Jinchang Power Supply Company focuses on people’s livelihood services and business environment optimization, providing convenient power services for market entities and the public through government-enterprise cooperation and Party building empowerment.
The company set up 3 Party member demonstration windows, launched special service campaigns, handled over 2,785 businesses in total, and shortened the approval process and time for enterprises to handle electricity services. It formed a flexible team of young backbones, forcing service compliance upgrading through cross-audit and error assessment. Meanwhile, it piloted “QR code shared electricity” services, with 6 sets of devices covering agricultural irrigation, street stalls and night markets, enabling “scan and use immediately”.
In addition, the company promoted supporting construction of charging facilities, realizing synchronous implementation of old community renovation and charging facilities, full reservation of charging pile capacity in new communities, and elimination of non-direct supply communities in the region. It effectively integrated power services into people’s livelihood scenarios, empowering people’s well-being improvement and local development with high-quality power supply.

Đề xuất
Nebu Ease Portable Nebulizer Claims Evaluated: 2026 Consumer Research Report on Mesh Nebulizer Technology, Respiratory Comfort Features, and What Buyers Should Verify
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations
Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas
Direct Meds GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference